SETT ATT PAVISA NEUROLEPTISKA SUBSTANSER I BLODSERUM, BLODPLASMA, URIN ELLER CELEBROSPINALVETSKA SAMT MEDEL OCH BEHALLARE FOR UTFORANDE AV SETTET

摘要

Neuroleptics are determined by incubating a dopamine receptor material, a radioactive dopamine receptor binder and a sample of human body fluid. Subsequently, the percentage inhibition of the binding of the radioactive compound to the dopamine receptor material is measured. The concentration of neuroleptics in the body fluid is determined using the measured percentage inhibition. The composition for carrying out this method contains a radioactive dopamine receptor binder, a neuroleptic, a dopamine receptor material and human body fluid. Neuroleptics in human body fluids such as blood serum and blood plasma can be determined in a straightforward manner by the method, which facilitates the choice of the individual optimal dosage of the neuroleptics for the individual patient.